{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T16:30:16Z","timestamp":1706805016111},"reference-count":12,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,11,28]]},"DOI":"10.1536\/ihj.20-333","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T22:07:14Z","timestamp":1605218834000},"page":"1303-1306","source":"Crossref","is-referenced-by-count":3,"title":["MitraClip or Ventricular Assist Device?"],"prefix":"10.1536","volume":"61","author":[{"given":"Shuhei","family":"Tanaka","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Stone GW, Lindenfeld J, Abraham WT, <i>et al<\/i>. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med 2018; 379: 2307-18.","DOI":"10.1056\/NEJMoa1806640"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Levy WC, Mozaffarian D, Linker DT, <i>et al<\/i>. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006; 113: 1424-33.","DOI":"10.1161\/CIRCULATIONAHA.105.584102"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pocock SJ, Ariti CA, McMurray JJ, <i>et al<\/i>.; Meta-Analysis Global Group in Chronic Heart Failure. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 2013; 34: 1404-13.","DOI":"10.1093\/eurheartj\/ehs337"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Goodwin M, Nemeh HW, Borgi J, Paone G, Morgan JA. Resolution of Mitral Regurgitation With Left Ventricular Assist Device Support. Ann Thorac Surg 2017; 104: 811-8.","DOI":"10.1016\/j.athoracsur.2017.02.016"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kassis H, Cherukuri K, Agarwal R, <i>et al<\/i>. Significance of residual mitral regurgitation after continuous flow left ventricular assist device implantation. JACC Heart Fail 2017; 5: 81-8.","DOI":"10.1016\/j.jchf.2016.09.014"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Estep JD, Starling RC, Horstmanshof DA, <i>et al<\/i>. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: Results from the ROADMAP Study. J Am Coll Cardiol 2015; 66: 1747-61.","DOI":"10.1016\/j.jacc.2015.07.075"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pagani FD, Aaronson KD, Kormos R, <i>et al<\/i>.; REVIVE-IT Investigators. The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy. J Heart Lung Transplant 2016; 35: 1277-83.","DOI":"10.1016\/j.healun.2016.09.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Imamura T, Kinugawa K, Hatano M, <i>et al<\/i>. Status 2 patients had poor prognosis without mechanical circulatory support. Circ J 2014; 78: 1396-404.","DOI":"10.1253\/circj.CJ-14-0077"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mehra MR, Goldstein DJ, Uriel N, <i>et al<\/i>. Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med 2018; 378: 1386-95.","DOI":"10.1056\/NEJMoa1800866"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Obadia JF, Messika-Zeitoun D, <i>et al<\/i>. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 2018; 379: 2297-306.","DOI":"10.1056\/NEJMoa1805374"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Packer M, Grayburn PA. New evidence supporting a novel conceptual framework for distinguishing proportionate and disproportionate functional mitral regurgitation. JAMA Cardiol 2020; 5: 469-75.","DOI":"10.1001\/jamacardio.2019.5971"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Al-Bawardy R, Vemulapalli S, Thourani VH, <i>et al<\/i>. Association of Pulmonary Hypertension With Clinical Outcomes of Transcatheter Mitral Valve Repair. JAMA Cardiol 2020; 5: 47-56.","DOI":"10.1001\/jamacardio.2019.4428"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/6\/61_20-333\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T03:46:09Z","timestamp":1606535169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/6\/61_20-333\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-333","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,28]]}}}